We want to change how ADHD is perceived and treated
Ten percent of the population has ADHD.
Today, Clinicians are blindfolded when it comes to finding the best treatment for ADHD.
iFocus is removing the blindfold!
iFocus is using eye-tracking technology combined with a proprietary AI algorithm to provide data-based treatment efficacy measures
Adi Diner was interviewed for the Distraction podcast
iFocus Measures How Well Your ADHD Treatments Work
“Distraction,” hosted by Dr. Edward Hallowell, child and adult psychiatrist, New York Times best-selling author, and leading authority in ADHD, explores how we are driven to distraction and offers coping strategies to turn modern problems into new-found strengths. It’s about insights, strategies and tactics for all, from those who occasionally lose their keys to those who spend hours online to those who wander away from a task – at work, at school, at home, at play – because they got distracted along the way.
The iFocus Team
Get to Know Us
Our passion for creating meaningful change for clients is what sets us apart.
The iFocus team believes in the potential of our great idea, and it truly shows in all of our work.
We work tirelessly in order to bring you a better tomorrow, and we’re proud of every single member of staff.
To learn more about the incredible iFocus team, please have a look below.
Adi Diner, PhD.
Adi has a Ph.D. in Physics from the Weizmann Institute of Science. Over the past 20 years, Adi has been leading the development of lasers, biotech, and medical devices. Adi’s expertise is finding original practical solutions for complex nearly impossible problems.
A mother to a kid with ADHD and an ADHDier. Adi applies her passion for learning, and out of the box thinking to find ways to improve the treatment for individuals with ADHD.
Einat Sitbon, PhD.
Data scientist and an expert in bioinformatics, Artificial Intelligence, Genetics, and advanced statistical analysis. Dr. Sitbon has over 20 years of extensive experience in computational biology research and algorithms development
Prof. Daniela Kaufer
Professor of Integrative Biology and Neuroscience, Associate Dean of Biological Sciences at UC Berkeley. Founder of Mend Neurosciences Inc. Advisor for Emagix
Strategy and Business Operations, Advisor
Yulie brings 12 years of expertise in medical devices, genomics, wearables, connected devices, Health IT, and AI/ML. Among her competencies are Product Roadmap and P&L Ownership, Market Access Strategy Development, and Competitive Positioning Analysis.
She demonstrates a strong track record in building partnerships with key healthcare stakeholders such as Cigna, United Healthcare, Anthem, Kaiser Healthcare, Merck, Abbvie, Novartis, Sanofi, and GSK.
Yanxia Zhang, PhD.
Machine Learning Advisor
Yanxia has over a decade of experience in machine learning research. She is an expert in inventing novel data-driven technologies to sense and understand human behaviors and to solve real-world problems.